Julie-Aurore Losman

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Acute Kidney Injury

Top Venues

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn Gunn, Matti Myllykoski, John Z Cao, Manna Ahmed, Bofu Huang, Betty Rouaisnel, Bill H Diplas, Michael M Levitt, Ryan E Looper, John G Doench, Keith L Ligon, Harley I Kornblum, Samuel K McBrayer, Hai Yan, Cihangir Duy, Lucy A Godley, Peppi Karppinen, Julie-Aurore Losman
(R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers. Cancer discovery (2023)
Pavan K Bendapudi, Sumaiya Nazeen, Justine Ryu, Onuralp Soylemez, Alissa K Robbins, Betty Rouaisnel, Jillian K O'Neil, Ruchika Pokhriyal, Moua Yang, Meaghan Colling, Bryce Pasko, Michael Bouzinier, Lindsay Tomczak, Lindsay Collier, David A Barrios, Sanjay Ram, Agnes Toth-Petroczy, Joel Krier, Elizabeth Fieg, Walter 'Sunny' Dzik, James C Hudspeth, Damodaran Narayanan, Valentina Nardi, James R Knight, Richard Maas, Shamil Sunyaev, Julie-Aurore Losman
Low-frequency inherited complement receptor variants are associated with purpura fulminans. Blood (2023)
Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, Amin H Sabet, Amir Vajdi, Thomas Denize, Emily Walton, Yasmin Nabil Laimon, John G Doench, Navin R Mahadevan, Julie-Aurore Losman, David A Barbie, Michael Y Tolstorukov, Charles M Rudin, Triparna Sen, Sabina Signoretti, Matthew G Oser
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1. Nature communications 13 (1) (2022)